It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
-
The Role of Scientific Advisers in the English Patents Court
-
Trying to Make Sense of the Oracle of G 2/21: T 116/18 vs. T 681/21
-
Patent case: NanoString Technologies vs. 10x Genomics and President and Fellows of Harvard College, UPC
-
Patent case: Judgment no. 141/2023 dated 5 December 2023, Spain
Random Articles:
-
The Bible and patent law
-
CJEU declines to assess unfriendly SPCs based on third-party MAs in Eli Lilly v. Genentech (C-239/19)
-
USA: Airbus S.A.S. v. Firepass Corporation, United States Court of Appeals, Federal Circuit, 2014-1808, 17 July 2015
-
Patent case: Fahrradkomponenten-montiervorrichtung, Germany
-
Public Prior Use of a Pharmaceutical Preparation (T 2458/09)
-
Patent case: Actavis UK Limited v Eli Lilly, United Kingdom
-
Patent case: Novartis AG vs. Pharmathen Global B.V., Netherlands
-
Italian Chamber of Deputies approves bill to ratify Unified Patent Court Agreement
-
A “cover” utility model might still do the trick
-
Escitalopram injunctions granted in Denmark based on reversed burden of proof